Prevention of hepatocellular carcinoma: the holy grail of hepatitis B treatment.
Sherman
Morris
M
D000367:Age Factors; D000410:Alanine Transaminase / Q000378:metabolism; D000998:Antiviral Agents / Q000191:economics / Q000627:therapeutic use*; D006528:Carcinoma, Hepatocellular / Q000209:etiology / Q000517:prevention & control*; D003362:Cost-Benefit Analysis; D018450:Disease Progression; D006509:Hepatitis B / Q000150:complications / Q000188:drug therapy* / Q000191:economics; D006515:Hepatitis B virus / Q000502:physiology; D006801:Humans; D008099:Liver / Q000201:enzymology / Q000821:virology; D008113:Liver Neoplasms / Q000209:etiology / Q000517:prevention & control*; D019562:Viral Load
D000998:Antiviral Agents; D000410:Alanine Transaminase